Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Moraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S. pyogenes with human epithelial cells.

Literature DB >> 15501804

Moraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S. pyogenes with human epithelial cells.

Eric R Lafontaine¹, David Wall, Serena L Vanlerberg, Haig Donabedian, Darren D Sledjeski.

Abstract

The pathogens Streptococcus pyogenes and Moraxella catarrhalis colonize overlapping regions of the human nasopharynx. We have found that M. catarrhalis can dramatically increase S. pyogenes adherence to human epithelial cells and that species-specific coaggregation of these bacteria correlates with this enhanced adherence.

Entities: Species

Mesh：

Year: 2004 PMID： 15501804 PMCID： PMC523028 DOI： 10.1128/IAI.72.11.6689-6693.2004

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

32 in total

1. Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o-.

Authors: H Wan; H L Winton; C Soeller; G A Stewart; P J Thompson; D C Gruenert; M B Cannell; D R Garrod; C Robinson
Journal: Eur Respir J Date: 2000-06 Impact factor: 16.671

2. The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children.

Authors: Patricia Stutzmann Meier; Rolf Troller; Ioanna N Grivea; George A Syrogiannopoulos; Christoph Aebi
Journal: Vaccine Date: 2002-03-15 Impact factor: 3.641

Review 3. Moraxella (Branhamella) catarrhalis: clinical, microbiological and immunological features in lower respiratory tract infections.

Authors: J J Christensen
Journal: APMIS Suppl Date: 1999

Review 4. The microbiologic and immunologic basis for recurrent otitis media in children.

Authors: H Faden
Journal: Eur J Pediatr Date: 2001-07 Impact factor: 3.183

5. A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice.

Authors: G B Lesinski; S L Smithson; N Srivastava; D Chen; G Widera; M A Westerink
Journal: Vaccine Date: 2001-02-08 Impact factor: 3.641

6. The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro.

Authors: E R Lafontaine; L D Cope; C Aebi; J L Latimer; G H McCracken; E J Hansen
Journal: J Bacteriol Date: 2000-03 Impact factor: 3.490

Review 7. Pathogenesis of group A streptococcal infections.

Authors: M W Cunningham
Journal: Clin Microbiol Rev Date: 2000-07 Impact factor: 26.132

8. Identification of a Porphyromonas gingivalis receptor for the Streptococcus gordonii SspB protein.

Authors: W O Chung; D R Demuth; R J Lamont
Journal: Infect Immun Date: 2000-12 Impact factor: 3.441

Review 9. Moraxella catarrhalis: a review of an important human mucosal pathogen.

Authors: R Karalus; A Campagnari
Journal: Microbes Infect Date: 2000-04 Impact factor: 2.700

10. Role of the Streptococcus gordonii SspB protein in the development of Porphyromonas gingivalis biofilms on streptococcal substrates.

Authors: Richard J Lamont; Azza El-Sabaeny; Yoonsuk Park; Guy S Cook; J William Costerton; Donald R Demuth
Journal: Microbiology Date: 2002-06 Impact factor: 2.777

15 in total

1. Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells.

Authors: Andrew M Edwards; Tracy J Grossman; Joel D Rudney
Journal: Infect Immun Date: 2006-01 Impact factor: 3.441

Review 2. Comparison of European and U.S. results for cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis.

Authors: M Pichichero; J Casey
Journal: Eur J Clin Microbiol Infect Dis Date: 2006-06 Impact factor: 3.267

3. Adhesion of Moraxella catarrhalis to human bronchial epithelium characterized by a novel fluorescence-based assay.

Authors: Hortense Slevogt; Krishna N Tiwari; Bernd Schmeck; Andreas Hocke; Bastian Opitz; Norbert Suttorp; Joachim Seybold
Journal: Med Microbiol Immunol Date: 2005-07-30 Impact factor: 3.402

4. Microbiological Features of Upper Respiratory Tract Infections in Bulgarian Children for the Period 1998-2014.

Authors: Raina Tzvetanova Gergova; Guergana Petrova; Stefan Gergov; Petko Minchev; Ivan Mitov; Tanya Strateva
Journal: Balkan Med J Date: 2016-11-01 Impact factor: 2.021

Review 5. Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors: Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal: Clin Microbiol Rev Date: 2019-07-03 Impact factor: 26.132

6. Penicillin failure in the treatment of streptococcal pharyngo-tonsillitis.

Authors: Itzhak Brook
Journal: Curr Infect Dis Rep Date: 2013-06 Impact factor: 3.725

7. Protective mechanisms of respiratory tract Streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection.

Authors: Tomas Fiedler; Catur Riani; Dirk Koczan; Kerstin Standar; Bernd Kreikemeyer; Andreas Podbielski
Journal: Appl Environ Microbiol Date: 2012-12-14 Impact factor: 4.792

Review 8. The role of the local microbial ecosystem in respiratory health and disease.

Authors: Wouter A A de Steenhuijsen Piters; Elisabeth A M Sanders; Debby Bogaert
Journal: Philos Trans R Soc Lond B Biol Sci Date: 2015-08-19 Impact factor: 6.237

9. Differential virulence gene expression of group A Streptococcus serotype M3 in response to co-culture with Moraxella catarrhalis.

Authors: Suzanne J C Verhaegh; Anthony R Flores; Alex van Belkum; James M Musser; John P Hays
Journal: PLoS One Date: 2013-04-23 Impact factor: 3.240

Review 10. Viral and bacterial interactions in the upper respiratory tract.

Authors: Astrid A T M Bosch; Giske Biesbroek; Krzysztof Trzcinski; Elisabeth A M Sanders; Debby Bogaert
Journal: PLoS Pathog Date: 2013-01-10 Impact factor: 6.823